Your browser doesn't support javascript.
loading
Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?
Buchegger, F; Mach, J-P; Press, O W; Bischof Delaloye, A; Larson, S M; Prior, J O; Ketterer, N.
Affiliation
  • Buchegger F; Department of Nuclear Medicine, Lausanne University Hospital, Lausanne; Department of Nuclear Medicine, Geneva University Hospitals, Geneva. Electronic address: franz.buchegger@chuv.ch.
  • Mach JP; Department of Biochemistry, University of Lausanne, Lausanne, Switzerland.
  • Press OW; Department of Medical Oncology, University of Washington Medical Center, Seattle, USA.
  • Bischof Delaloye A; Faculty of Medicine, University of Lausanne, Lausanne, Switzerland.
  • Larson SM; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Prior JO; Department of Nuclear Medicine, Lausanne University Hospital, Lausanne.
  • Ketterer N; Clinic Bois-Cerf, Onco-Hematology, Lausanne, Switzerland.
Ann Oncol ; 24(7): 1948-1949, 2013 Jul.
Article in En | MEDLINE | ID: mdl-23704203
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Lymphoma, Follicular / Lymphoma, Large B-Cell, Diffuse Limits: Humans Language: En Year: 2013 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Lymphoma, Follicular / Lymphoma, Large B-Cell, Diffuse Limits: Humans Language: En Year: 2013 Type: Article